Quale sarebbe il prezzo per TME Pharma N.V. (ALTME)

Il prezzo per TME Pharma N.V. (ALTME) è $0.07591393

Qual è la capitalizzazione di mercato per TME Pharma N.V. (ALTME)

La capitalizzazione di mercato per TME Pharma N.V. (ALTME) è $7.15M

TME Pharma N.V. (ALTME) Prezzo e Capitalizzazione di Mercato

TME Pharma N.V., a biopharmaceutical company in the clinical development stage based in Berlin, Germany, is dedicated to pioneering innovative therapeutic solutions for cancer. The company leverages its unique Spiegelmer platform to advance a pipeline of investigational drug candidates. Its primary oncology asset, NOX-A12, is currently being evaluated in clinical studies as a combination therapy for a range of challenging cancers, including metastatic pancreatic and colorectal cancer, glioblastoma, and myeloma. Beyond its cancer-focused efforts, TME Pharma also developed NOX-E36, which has successfully concluded Phase 1/2 clinical trials for diabetic nephropathy. The company has formed a strategic collaboration with Merck Sharp & Dohme Corp. to explore NOX-A12 in combination with Keytruda and two different chemotherapy protocols as a second-line intervention for patients battling metastatic pancreatic cancer. Founded in 1997, the organization adopted its current name, TME Pharma N.V., in July 2022, having previously operated as NOXXON Pharma N.V.

Il prezzo per ALTME	Attivo B	Capitalizzazione del mercato a B	Risultati
$57,880.05 $7.15M	NVDA	$5.452T	+76,244,200.20%
$47,668.54 $7.15M	AAPL	$4.490T	+62,792,774.37%
$44,190.42 $7.15M	GOOG	$4.162T	+58,211,108.67%
$39,030.09 $7.15M	MSFT	$3.676T	+51,413,501.77%
$30,077.15 $7.15M	AMZN	$2.833T	+39,619,964.72%

Il prezzo per ALTME

Attivo B

Capitalizzazione del mercato a B

Risultati

$57,880.05 $7.15M